<DOC>
	<DOC>NCT00042250</DOC>
	<brief_summary>To determine cell cycle parameters and changes after treatment, the labelling agent is given and a bone marrow aspiration is accomplished before treatment and after treatment for comparison. Participants must be undergoing concurrent therapy for hematologic malignancy.</brief_summary>
	<brief_title>IUdR/BUdR Cell Cycle Labelling</brief_title>
	<detailed_description>Cell cycle parameters include LI, Ts, Tc, T dpot, changes in these parameters, and differences between normal and leukemic cells in patients with hematologic malignancy prior to and following treatment.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Histologic proof of one of: AML, ALL, or AUL MDS or CMML CML OR undergoing bone marrow transplantation. Participants should be: off therapy for at least two weeks At least 18 years old or older Using adequate contraception if of childbearing capability.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Cell Cycle Interphase</keyword>
	<keyword>G0</keyword>
	<keyword>G1</keyword>
	<keyword>G2</keyword>
	<keyword>S Phase</keyword>
</DOC>